Diabetes Type 2

>

Latest News

Semaglutide vs Tirzepatide for Weight Loss in Persons with Obesity: Daily Dose / image credit: ©New Africa/AdobeStock
Semaglutide vs Tirzepatide for Weight Loss in Persons with Obesity: Daily Dose

July 18th 2024

Your daily dose of the clinical news you may have missed.

Roche Oral Incretin Mimetic CT-966 Moves to Phase 2 Clinical Development / image credit Roche logo: ©Sundry Photography/stock.adobe.com
Roche Oral Incretin Mimetic CT-966 Moves to Phase 2 Clinical Development

July 17th 2024

GLP-1RAs Reduce Risk of Some Obesity-Related Cancers in Patients with T2D: Daily Dose / image credit: ©New Africa/AdobeStock
GLP-1RAs Reduce Risk of Some Obesity-Related Cancers in Patients with T2D: Daily Dose

July 15th 2024

Remaining Free of Diabetes for at Least 4 Years Improves Long-Term Health in Persons with Impaired Glucose Tolerance
Remaining Free of Diabetes for at Least 4 Years Improves Long-Term Health in Persons with Impaired Glucose Tolerance

July 11th 2024

Workplace Sexual Harassment Linked to Higher Risk of Cardiometabolic Diseases: Daily Dose / image credit: ©New Africa/AdobeStock
Workplace Sexual Harassment Linked to Higher Risk of Cardiometabolic Diseases: Daily Dose

July 9th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.